MiNK Therapeutics(INKT) - 2023 Q3 - Earnings Call Transcript

Zack Armen â Head, Investor Relations Jennifer Buell - President and Chief Executive Officer Marc Van Dijk - Chief Scientific Officer Christine Klaskin â Principal Financial and Accounting Officer Good morning, and welcome to MiNK Therapeutics' Third Quarter 2023 Conference Call and Webcast. All participants will be in a listen-only mode until the question-and-answer session. Please note this event is being recorded. If anyone has any objections, you may now disconnect at this time. I'd like to remind you t ...